Botanical Therapeutics for Parkinson's Disease

被引:2
作者
Li, Wen-wei [1 ,2 ,3 ]
机构
[1] Fudan Univ, Dept Neurol, Shanghai Publ Hlth Clin Ctr, Shanghai 201500, Peoples R China
[2] Fudan Univ, Zhongshan Hosp South Branch, Dept Neurol, Shanghai 201500, Peoples R China
[3] Fudan Univ, Inst Integrat Med, Inst Neurol, Shanghai 201500, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; botanical therapeutics; Chinese medicine; neurotrophic activity; protein aggregation; neuroinflammation; TRADITIONAL CHINESE MEDICINE; CLINICAL DIAGNOSTIC-CRITERIA; ALPHA-SYNUCLEIN; WITHANIA-SOMNIFERA; MUCUNA-PRURIENS; DOUBLE-BLIND; AUTOPHAGY; DOPAMINE; CLEARANCE; MICROGLIA;
D O I
10.1007/s11655-020-3096-5
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Parkinson's disease (PD) was first formally described by James Parkinson in 1817, but the shaking of limbs was described in the literature of several ancient civilizations, such as ancient Chinese civilization and ancient Indian civilization. Historically, botanical drugs were used as the main source for the treatment of such kind of disorders. In Western countries, plant extracts also occupied an important place in the earlier medications of PD. With the adventure of synthetic drugs, the role of plant-derived drugs in management of PD has been diminished. Nowadays, there is still no cure for PD, dopaminergic (DA) medication is the treatment of choice, which is just designed to ameliorate symptoms of PD, and long-term use of DA medication will result in reduced efficacy and severe adverse reactions. It is necessary to explore new methods for the treatment of PD. Chinese medicine (CM) developed a holistic and unique theoretical system, and botanical drugs are widely used in practice for more than two millennia. Modern pharmacological studies have proved that Chinese herbs have potential therapeutic effects on PD, such as enhancing neurotrophic activity, clearing protein aggregates, regulating neuroinflammation, etc. All the advances provide us with hope for developing CM as a mainstream medication for treating PD.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 81 条
[71]   Jean-Martin Charcot and Parkinson's disease: Teaching and teaching materials [J].
Walusinski, O. .
REVUE NEUROLOGIQUE, 2018, 174 (7-8) :491-505
[72]   Chinese Medicine for Idiopathic Parkinson's Disease: A Meta Analysis of Randomized Controlled Trials [J].
Wei Wei ;
Chen Hai-yong ;
Fan Wen ;
Ye Shui-fen ;
Xu Yi-hui ;
Cai Jing .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2017, 23 (01) :55-61
[73]   CATALPOL ATTENUATES MPTP INDUCED NEURONAL DEGENERATION OF NIGRAL-STRIATAL DOPAMINERGIC PATHWAY IN MICE THROUGH ELEVATING GLIAL CELL DERIVED NEUROTROPHIC FACTOR IN STRIATUM [J].
Xu, G. ;
Xiong, Z. ;
Yong, Y. ;
Wang, Z. ;
Ke, Z. ;
Xia, Z. ;
Hu, Y. .
NEUROSCIENCE, 2010, 167 (01) :174-184
[74]  
Zhang Qiu-Juan, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P75
[75]   Baicalein exerts anti-neuroinflammatory effects to protect against rotenone-induced brain injury in rats [J].
Zhang, Xue ;
Yang, Yulin ;
Du, Lida ;
Zhang, Wen ;
Du, Guanhua .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 50 :38-47
[76]  
[张永超 Zhang Yongchao], 2013, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V36, P805
[77]   Early descriptions of Parkinson disease in ancient China [J].
Zhang, ZX ;
Dong, ZH ;
Román, GC .
ARCHIVES OF NEUROLOGY, 2006, 63 (05) :782-784
[78]   Therapeutic History of Parkinson's Disease in Chinese Medical Treatises [J].
Zheng, Guo-Qing .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2009, 15 (11) :1223-1230
[79]   MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease [J].
Zhou, Yan ;
Lu, Ming ;
Du, Ren-Hong ;
Qiao, Chen ;
Jiang, Chun-Yi ;
Zhang, Ke-Zhong ;
Ding, Jian-Hua ;
Hu, Gang .
MOLECULAR NEURODEGENERATION, 2016, 11
[80]   Transient exposure to echinacoside is sufficient to activate Trk signaling and protect neuronal cells from rotenone [J].
Zhu, Min ;
Lu, Chuanzhen ;
Li, Wenwei .
JOURNAL OF NEUROCHEMISTRY, 2013, 124 (04) :571-580